Price Chart

Profile

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
URL https://www.perspectivetherapeutics.com
Investor Relations URL https://perspectivetherapeutics.com/investor-center/
HQ State/Province Washington
Sector Health Care
Industry Biotechnology
Next Earnings Release Aug. 12, 2025 (est.)
Last Earnings Release May. 12, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
URL https://www.perspectivetherapeutics.com
Investor Relations URL https://perspectivetherapeutics.com/investor-center/
HQ State/Province Washington
Sector Health Care
Industry Biotechnology
Next Earnings Release Aug. 12, 2025 (est.)
Last Earnings Release May. 12, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A